Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment

BACKGROUND: Despite promising advances in stem cell-based therapy, the treatment of ischemic cardiovascular diseases remains a big challenge due to both the insufficient in vivo viability of transplanted cells and poor angiogenic potential of stem cells. The goal of this study was to develop therape...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Tissue Eng Regen Med
Main Authors: Jang, Woong Bi, Ji, Seung Taek, Park, Ji Hye, Kim, Yeon-Ju, Kang, Songhwa, Kim, Da Yeon, Lee, Na-Kyung, Kim, Jin Su, Lim, Hye Ji, Choi, Jaewoo, Le, Thi Hong Van, Ly, Thanh Truong Giang, Rethineswaran, Vinoth Kumar, Kim, Dong Hwan, Ha, Jong Seong, Yun, Jisoo, Baek, Sang Hong, Kwon, Sang-Mo
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7260304/
https://ncbi.nlm.nih.gov/pubmed/32227286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13770-020-00244-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados